Neuralgia,Postherpetic
Conditions
Brief summary
The efficiency of epidural steroid injection in patients who has postherpetic neuralgia is well known. In this study, the purpose is whether the continous epidural steroid injection is effective or not.
Detailed description
Continous epidural injection will be done during 10 days. D group will be injected a 0.19% ropivacaine 8mL and dexametasone 1mg every other day during 10 days. Continous epidural injection will be done during 10 days N group will be injected a 0.19% ropivacaine 8mL only every other day during 10 days
Interventions
DRUGDexamethasone
Continous epidural injection will be done during 10 days. D group will be injected a 0.19% ropivacaine 8mL and dexametasone 1mg every other day during 10 days. .
DRUGRopivacaine
Continous epidural injection will be done during 10 days Both group will be injected a 0.19% ropivacaine 8mL every other day during 10 days
Sponsors
Korea University Guro Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients who has herpes zoster * Patients has a period (at least 1month) after onset of herpes zoster * Patients has a definite symptom along dermatome * ASA class I - II * Age : 18 - 80 years
Exclusion criteria
* Patients who has a cancer * Patients who has a neurologic, psychologic, renal, hepatic and hematologic disease * Patients who has a other dermatologic disease * Patients who has major operation & procedure history * Patients who has a other pain origin * Patients who can not be inserted epidural catheter
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| VAS score | up to 10 days | The investigator set the primary outcome If there is a 50% reduction of VAS score. |
Countries
South Korea
Contacts
Primary ContactJung Eun Kim, MD, PhD
Outcome results
None listed